I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and safety of abemaciclib alone and with PI3K/mTOR..:
E. Gabriela Chiorean
;
Vincent Picozzi
;
Chung‐Pin Li
...
https://doi.org/10.1002/cam4.6621. , 2023
Link:
https://doi.org/10.1002/cam4.6621
RT Journal T1
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:361cb4c885cb4edb9ee2ff88993a88f9&Exemplar=1&LAN=DE A1 E. Gabriela Chiorean A1 Vincent Picozzi A1 Chung‐Pin Li A1 Marc Peeters A1 Joan Maurel A1 Jaswinder Singh A1 Talia Golan A1 Jean‐Frédéric Blanc A1 Sonya C. Chapman A1 Anwar M. Hussain A1 Erica L. Johnston A1 Howard S. Hochster PB Wiley YR 2023 K1 Abemaciclib K1 metastatic pancreatic cancer K1 PI3K/mTOR K1 TGFβ K1 second‐line therapy K1 third‐line therapy K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1002/cam4.6621 LK http://dx.doi.org/https://doi.org/10.1002/cam4.6621 DO https://doi.org/10.1002/cam4.6621 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)